Routine Health Screening Market

Global Routine Health Screening Market Size (2024 to 2029)

The global routine health screening market is projected to grow at a CAGR of 6.8% from 2024 to 2029 and be worth USD 81.7 billion by 2029 from USD 58.6 billion in 2024.

Current Scenario of the Global Routine Health Screening Market

Routine health screening is one of the most common ways to diagnose the disease at an early stage. Diagnosing the disease at an early stage can help completely cure the disease, and a person can be back to normal life with proper treatment procedures. There will be a high chance of a complete cure for the disease if it is diagnosed in the early stage. The health screening helps in diagnosing the underlying disease and helps in taking proper steps in treatment procedures. Actually, a health screening test detects the invisible disease that was not diagnosed in various other tests. Also, people who are anxious to check for hereditary diseases go for routine health screening tests that help them stay safe and lead a happy lifestyle.

MARKET DRIVERS

Y-o-Y growth in the number of people suffering from genetic abnormalities is majorly driving the routine health screening market growth.

According to WHO (World Health Organization), 1 in 50 people are diagnosed with genetic disorders or diseases around the world. WHO is encouraging various strategies to lower the risk of genetic disorders by introducing various diagnostic tests that help them to lower the risk of death. About 2-5% of all live births occur with genetical disorders and congenital abnormalities.

In addition, the rising popularity of the easy availability of routine health screening in various healthcare centers is prominently elevating the growth rate of the market. The launch of applications in smartphones where one can easily avail of the various options for screening purposes according to one's preferences is likely to fuel the market’s growth rate. Huge investments in the healthcare sector with direct support from government organizations are substantially prompting the routine health screening market. Government organizations are quietly opting to deliver high-quality treatment options to the public, which is greatly gearing up the demand to launch various diagnostic procedures. The rising number of campaigns to create awareness among the public over the benefits of routine health screening is likely to elevate the growth rate of the market.

Y-o-Y growth in the aging population and chronic disease population are further propelling the routine health screening market growth.

Changing lifestyle habits is one of the major causes of the increasing number of people diagnosed with life-threatening diseases, which may further lead to an increasing demand for various types of screening tests. This attribute shall accelerate the growth rate of the market. For instance, heart-related diseases are the major causing death currently across the world. Frequent health screening and regular follow-up on the health condition, along with maintaining healthy food habits, can seriously lower the risk of heart-related diseases, which is augmented in amplifying the growth rate of the routine health screening market.

The trend towards the rapid adoption of the latest technological developments with the increasing focus on maintaining proper health and wellness is solely to create huge growth opportunities for the routine health screening market. People are now more aware of the importance in routine health screening tests that decrease the risk of life-threatening factors is ascribed in levelling up the growth rate of the market.

MARKET RESTRAINTS

The high cost of installing or maintaining equipment is likely to impede the growth rate of the routine health screening market.

The equipment required to do the routine health screening is costly and cannot be affordable by small-scale companies, especially in undeveloped countries, which may potentially slow the market’s growth rate. Most of the screening tests cost very high, and common people cannot afford to regularly check on the tests, which slightly degrades the growth rate of the market. In addition, the lack of knowledge to resolve the technical issues in real-time that may delay the overall procedure is likely to hamper the growth rate of the routine health screening market. Frequent updates in the software of the screening devices are to decline the market’s growth rate.

The need to raise the number of service care providers with the growing need for healthcare facilities across the world is substantially to escalate the growth rate of the market.

The launch of different schemes by both private and public sectors in favor of the people raises the opportunities for regular health checkups. Some centers also provide various discount processes to attract customers, greatly influencing the market’s growth rate. Penetration of artificial intelligence in the healthcare industry is forwarding the future of genomic testing and biomarkers that are likely to promote the market’s growth rate. Many people are not aware of the benefits of routine health screening tests that help them avail themselves of the best treatment procedures, especially in remote areas, which is a big challenge for key market players. It is highly difficult for the key players to launch advanced techniques in the health care centers in remote areas. However, increasing awareness programs by the government authorities through TV channels is likely to overcome these challenges for the growth of the routine health screening market.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Routine Health Screening Market Analysis By Test Type

The blood glucose test segment is gaining huge traction over the share of the routine health screening market. Many studies reveal that routine screening tests are highly recommended for people who are obese or overweight to check for diabetes. Diabetes is becoming the most common disease in this generation, where regular checkups are mandatory to keep control of glucose levels, which completely avoids the risk of other factors.

The lipid profile test has the fastest growth opportunities during the forecast period. The rising number of people visiting hospitals due to various health-related problems and increasing prominence for high-quality treatment procedures will greatly influence this segment’s growth rate during the forecast period.

Global Routine Health Screening Market Analysis By Sample Type

The blood and urine segments are likely to have the most prominent share in the routine health screening market. Most diagnostic procedures basically go for blood and urine tests to detect the infection or any other diseases, which is a factor that leverages the growth rate of the market. The rising number of viral or infectious diseases all around the world is showcasing the demand for blood and urine screening tests that help prescribe the best treatment procedure. Serum segment is gaining huge traction over the share of the market in the coming years.

Global Routine Health Screening Market Analysis By Sample Collection Sites

The hospitals segment has had the most prominent growth rate for many years and is expected to continue the same flow in the coming years as well. The growing scale of hospital sectors everywhere is to promote new opportunities for the routine health screening market in the coming years. In today’s world, the support from the government through subsidies is quietly increasing, where the focus on availing the best treatment options to live a quality life is straightforward to propel the market’s growth rate. The increasing number of diagnostic laboratories with advanced equipment is setting up a new trend in today’s world. Routine health screening tests have become easy with the presence of the latest equipment in diagnostic laboratories.

REGIONAL ANALYSIS

Asia-Pacific had the largest share of the routine health screening market in 2023.

The rising number of elderly people in the most populous countries like India and China is the major attribute that bolsters the growth rate of the market in this region. As years go on, people are more likely to get diagnosed with several chronic diseases, which increases the need for regular checkups. The number of people aged more than 60 years suffering from chronic diseases is around 81.1% in 2023, according to the Journal of the American Medical Directors Association.

North America is likely to hit the highest CAGR by the end of 2029.

The U.S. and Canada are the most developed countries, and a number of people have cleanly adapted to sedentary lifestyles. Working for so long hours and having an interest in smoking and alcohol further leverages the number of people diagnosed with various diseases like obesity, cancer, hypertension, and others. All these factors are ascribed to boosting the growth rate of the market in North America.

Europe is another notable regional segment in the worldwide routine health screening market.

High per capita income and the presence of the top healthcare industries in the UK, Germany, and other countries are likely to boost the growth rate of the market. Latin America, the Middle East, and Africa are likely to have prominent opportunities in the coming years.

KEY PLAYERS IN THE GLOBAL ROUTINE HEALTH SCREENING MARKET

Companies playing a prominent role in the global Routine Health Screening Market profiled in this report Quest Diagnostics Incorporated, GRAIL, Eurofins Scientific, Exact Sciences Corporation, SYNLAB International GmbH, UNILABS, LabPLUS, BioReference Laboratories, Sonic Healthcare Limited, ACM Global Laboratories, Cerba Healthcare, Quidel Corporation, Innova Medical Group, Amedes Holding GmbH, RadNet, Inc., Natera, Inc., Trinity Biotech.

RECENT HAPPENINGS IN THE MARKET

• In 2024, Labcorp, a global leader of innovative and comprehensive laboratory services, acquired the selected assets of BioReference Laboratories. The major aim of this acquisition is to focus on clinical diagnostics tests and reproductive and women’s health across the United States. Bioreference laboratories are expected to expand their portfolio in New York and New Jersey.

DETAILED SEGMENTATION OF GLOBAL ROUTINE HEALTH SCREENING MARKET INCLUDED IN THIS REPORT

This research report on the global routine health screening market has been segmented and sub-segmented based on test type, sample type, sample collection sites & region.

By Test Type

• Blood Glucose Test
• Kidney Function Test
• Bone Profile Test
• Electrolyte Test
• Liver Function Test
• Lipid Profile Test
• Others

By Sample Type

• Blood
• Urine
• Serum
• Saliva
• Others

By Sample Collection Sites

• Hospitals
• Homes
• Diagnostic Laboratories
• Offices
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa